In a phase 2 trial, a gene therapy reduced angioedema attacks, which could significantly change the quality of life for ...

Patients with metastatic non-small cell lung cancer, even those with brain metastases, experienced improved longer-term ...

In a new study of patients with metastatic non-small cell lung cancer, researchers found that patients who were more physically fit had better outcomes. With lung cancer claiming around 1.8 million ...

After feedback from the FDA, the companies have voluntarily withdrawn the previous biologics licensing application for ...

ICER Gives Cell Therapy for Post-Transplant Complications High Rating ...

ICER Gives Cell Therapy for Post-Transplant Complications High Rating ...

Seemal Desai, M.D., FAAD, discusses how immune system dysregulation and genetic variants intersect to trigger vitiligo development while highlighting diagnostic challenges including identifying ...

Managed Healthcare Executive provides C-suite executives at health plans and provider organizations with news, analysis, insights, and strategies to pursue value-driven solutions.

Current financial screening procedures in the United States may need to change, according to recent research done by Laila ...

People with multiple sclerosis (MS) often stop taking disease-modifying therapy as they transition from relapsing-remitting MS to secondary progressive MS. This study shows that people who stop stop ...

ICER Gives Cell Therapy for Post-Transplant Complications High Rating ...

The company recently announced promising results from its phase 2a clinical of an agent that the company says is the first to target Traf2- and NCK-interacting kinase, or TNIK for short.